The FDA examined the final rule as prescribed by the Act and found that no mandate will be imposed on State , local or tribal governments and it believes that the burden on the private sector will be below the $ 100 million annual expenditure level to require compliance with the Act .
The burden of the private sector will be below $ 100 million .